Expert Opinion on Investigational Drugs, Volume 17, Issue 2 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 17, Issue 2 (2008)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Volume 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Reviews

Article
Recent developments in the therapy of irritable bowel syndrome
Richard J Saad MD & William D Chey MD AGAF FACG FACP
Pages: 117-130
Published online: 30 Jan 2008
AbstractforRecent developments in the therapy of irritable bowel syndrome | Full Text | References | PDF (178.2 KB)
  • 210 Views
  • 11 CrossRef citations
  • 0Altmetric

Review

Article
Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species
Varsha Gupta
Pages: 131-143
Published online: 30 Jan 2008
AbstractforMetallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species | Full Text | References | PDF (157.3 KB)
  • 534 Views
  • 70 CrossRef citations
  • 0Altmetric
Article
Glucokinase activators in diabetes management
Matthew Coghlan & Brendan Leighton
Pages: 145-167
Published online: 30 Jan 2008
AbstractforGlucokinase activators in diabetes management | Full Text | References | PDF (406.5 KB)
  • 395 Views
  • 96 CrossRef citations
  • 0Altmetric
Article
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders
Eric Hahnen PhD MBA, Jan Hauke, Christian Tränkle, Ilker Y Eyüpoglu, Brunhilde Wirth & Ingmar Blümcke
Pages: 169-184
Published online: 30 Jan 2008
AbstractforHistone deacetylase inhibitors: possible implications for neurodegenerative disorders | Full Text | References | PDF (201.2 KB)
  • 800 Views
  • 133 CrossRef citations
  • 0Altmetric
Article
New developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination
Eli E Bar & Duncan Stearns
Pages: 185-195
Published online: 30 Jan 2008
AbstractforNew developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination | Full Text | References | PDF (672.3 KB)
  • 197 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
Axel H Schönthal, Thomas C Chen, Florence M Hofman, Stan G Louie & Nicos A Petasis
Pages: 197-208
Published online: 30 Jan 2008
AbstractforCelecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs | Full Text | References | PDF (161.2 KB)
  • 318 Views
  • 68 CrossRef citations
  • 0Altmetric

Drug Evaluations

Article
An update on huperzine A as a treatment for Alzheimer's disease
John T Little MD, Sally Walsh MB MRCPsych & Paul S Aisen MD
Pages: 209-215
Published online: 30 Jan 2008
AbstractforAn update on huperzine A as a treatment for Alzheimer's disease | Full Text | References | PDF (115 KB)
  • 406 Views
  • 51 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
The use of dexrazoxane for the prevention of anthracycline extravasation injury
Brian B Hasinoff PhD
Pages: 217-223
Published online: 30 Jan 2008
AbstractforThe use of dexrazoxane for the prevention of anthracycline extravasation injury | Full Text | References | PDF (129.4 KB)
  • 337 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens
Garyphallia Poulakou MD & Helen Giamarellou MD PhD
Pages: 225-243
Published online: 30 Jan 2008
AbstractforOritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens | Full Text | References | PDF (205.7 KB)
  • 151 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria
Kimberlee Michals-Matalon PhD RD
Pages: 245-251
Published online: 30 Jan 2008
AbstractforSapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria | Full Text | References | PDF (132.4 KB)
  • 252 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
Guru Sonpavde MD, Thomas E Hutson DO PharmD FACP & Cora N Sternberg MD FACP
Pages: 253-261
Published online: 30 Jan 2008
AbstractforPazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma | Full Text | References | PDF (873.6 KB)
  • 596 Views
  • 71 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy
Ava Aghakhani et al.
Review Article | Published online: 30 May 2024
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus
Eric F. Morand et al.
Plain Language Summary of Publication | Published online: 29 May 2024
Open Access
Inflammation and Huntington’s disease – a neglected therapeutic target?
Sophie E. Field et al.
Review Article | Published online: 29 May 2024
Open Access
Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration
Shogo Hashimoto et al.
Review Article | Published online: 29 May 2024
View all latest articles